Maze Therapeutics (MAZE) Interest & Investment Income (2024 - 2026)

Maze Therapeutics has disclosed Interest & Investment Income across 3 years of filings, most recently posting $3.2 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $3.2 million, up 22.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.4 million (up 77.09% YoY), and the FY2025 annual result was $11.8 million, up 153.09% from the prior year.
• Interest & Investment Income came in at $3.2 million for Q1 2026 at Maze Therapeutics, down from $3.5 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.5 million in Q4 2025 to a low of $281000.0 in Q1 2024.
• The 3-year median for Interest & Investment Income is $2.6 million (2025), against an average of $2.2 million.
• Across the five-year window, Interest & Investment Income surged 830.6% in 2025 and climbed 22.79% in 2026, its largest moves.
• Maze Therapeutics' Interest & Investment Income stood at $1.5 million in 2024, then jumped by 130.28% to $3.5 million in 2025, then dropped by 8.02% to $3.2 million in 2026.
• The last three Interest & Investment Income figures came in at $3.2 million (Q1 2026), $3.5 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.